Overview

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Study will assess PK/PD parameters and safety and tolerability of the study medication in this age group
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran